Sessa Capital Im, L.P. Galapagos Nv Transaction History

Sessa Capital Im, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$37.44 - $46.51 $1.33 Million - $1.65 Million	-35,417 Reduced 43.19%	46,583 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $7.94 Million - $12.2 Million	82,000 New	82,000 $8.12 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.69B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

Stay updated on Sessa Capital Im, L.P. with notifications on news.